FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2707-2709 December 22, 2005 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group PubMed Citation

Improved glycemic control reduces the risks of early microvascular complications, such as retinopathy, nephropathy, and neuropathy, in patients with diabetes.^1,2 Such patients also have a markedly increased risk of macrovascular complications — myocardial infarction and stroke — as compared with persons without diabetes, and cardiovascular disease is the chief cause of death among patients with either type 1 or type 2 diabetes.^3,4 The increased risk appears to be only partially explained by traditional risk factors. Whereas we recognize that the development of atherosclerosis is multifactorial, there is substantial evidence linking chronic hyperglycemia to an increased risk of cardiovascular disease among . . . [Full Text of this Article]

Source Information

From the Division of Nutrition and Chronic Diseases, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge.

Related Letters:

Intensive Diabetes Treatment and Cardiovascular Disease
Weissman A. J., Ross P. S., Nathan D. M., Genuth S., Lachin J., Cefalu W. T.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1751-1752, Apr 20, 2006. Correspondence

This article has been cited by other articles:

• American Diabetes Association, (2007). Standards of Medical Care in Diabetes--2007. Diabetes Care 30: S4-S41 [Full Text]  
• Shankar, A., Klein, R., Klein, B. E.K., Nieto, F. J., Moss, S. E. (2007). Relationship Between Low-Normal Blood Pressure and Kidney Disease in Type 1 Diabetes. Hypertension 49: 48-54 [Abstract] [Full Text]  
• Iannotti, R. J., Nansel, T. R., Schneider, S., Haynie, D. L., Simons-Morton, B., Sobel, D. O., Zeitzoff, L., Plotnick, L. P., Clark, L. (2006). Assessing Regimen Adherence of Adolescents With Type 1 Diabetes. Diabetes Care 29: 2263-2267 [Abstract] [Full Text]  
• Ramasamy, R., Yan, S. F., Schmidt, A. M. (2006). Sphingosine-1-Phosphate: Waging a Battle in the Diabetic Blood Vessel. Circ. Res. 99: 669-671 [Full Text]  
• Weissman, A. J., Ross, P. S., Nathan, D. M., Genuth, S., Lachin, J., Cefalu, W. T. (2006). Intensive diabetes treatment and cardiovascular disease.. NEJM 354: 1751-1752 [Full Text]  
• (2006). Tight Control of Diabetes and Cardiovascular Disease. JWatch Pediatrics 2006: 3-3 [Full Text]  
• (2006). Glycemic Control and Macrovascular Complications in Type 1 Diabetes. JWatch General 2006: 1-1 [Full Text]  
• (2006). Effect of Tight Glucose Control on CV Outcomes in Type 1 Diabetes. Journal Watch Cardiology 2006: 4-4 [Full Text]